WASEEMA TAJAMMUL: Open Payments
NPI 1790128502 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 8 payments from 4 companies in 2025. Trend: 2023 $26 · 2024 $14 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: UZEDY, ABILIFY MAINTENA, AUSTEDO XR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across IL — which companies pay providers there.
